Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Structure Therapeutics Inc. Sponsored ADR (GPCR) had Operating Cash Flow per Share of $-0.91 for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-46.83M |
|
-- |
|
-- |
|
$56.31M |
|
$-56.31M |
|
$9.58M |
|
$-46.73M |
|
$-46.73M |
|
$-46.83M |
|
$-46.83M |
|
$-46.83M |
|
$-46.83M |
|
$-56.31M |
|
$-61.23M |
|
57.35M |
|
57.35M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$849.62M |
|
$3.52M |
|
$16.93M |
|
$866.55M |
|
$36.49M |
|
-- |
|
$5.42M |
|
$41.91M |
|
$824.64M |
|
$824.64M |
|
$824.64M |
|
57.54M |
|
| Cash Flow Statement Financials | |
$-52.23M |
|
$34.03M |
|
$0.81M |
|
$169.51M |
|
$152.12M |
|
$-17.39M |
|
$5.92M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
23.29 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-52.54M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.68% |
|
-5.68% |
|
-5.40% |
|
-5.68% |
|
$14.33 |
|
$-0.92 |
|
|
Operating Cash Flow per Share |
$-0.91 |